COSIRA: COronary SInus
Reducer for Treatment of
Refractory Angina
Positive results from the COSIRA clinical trial assessing the
efficacy and safety of the Neovasc Reducer published
in The New England Journal of Medicine.
Tiara: Minimally invasive
treatment for a
common form
of mitral valve
disease
Potential new therapeutic option
for millions of patients
This product is an investigational device only.
It is not approved in any geography.
Reducer: A novel device for the
treatment of Refractory Angina
Potential relief of symptoms
for those suffering from
persistent angina pain
This device is currently only
available in the EU.
© 2018 Neovasc Inc.
